World News

FDA Grants Accelerated Approval to Elranatamab-bcmm for Multiple Myeloma

Ogkologos - 26 Σεπτεμβρίου, 2023

EMA Adopts a Positive Opinion for Dabrafenib for the Treatment of...

Ogkologos - 25 Σεπτεμβρίου, 2023

NALIRIFOX Improves Survival Compared with Nab-paclitaxel Plus Gemcitabine in First-Line Treatment...

Ogkologos - 22 Σεπτεμβρίου, 2023

2023 ASCO Annual Meeting Research Round Up: Improving Symptom Monitoring and...

Ogkologos - 21 Σεπτεμβρίου, 2023

A Robust, Durable Activity of Atezolizumab Observed in a Diverse Cohort...

Ogkologos - 21 Σεπτεμβρίου, 2023

Could Bacteria Help Find Cancer?

Ogkologos - 20 Σεπτεμβρίου, 2023

No Clinically Meaningful Difference in Survival Between Nivolumab Plus Ipilimumab and...

Ogkologos - 20 Σεπτεμβρίου, 2023

Does Eating Processed Meat Increase Your Risk for Cancer?

Ogkologos - 19 Σεπτεμβρίου, 2023

Dabrafenib Plus Trametinib Improves Efficacy in Children and Adolescents with Relapsed/Refractory...

Ogkologos - 19 Σεπτεμβρίου, 2023

Sacituzumab Govitecan Demonstrates Overall Survival Benefit Over Chemotherapy in Patients with...

Ogkologos - 18 Σεπτεμβρίου, 2023

1...110111112...432 Σελίδα 111 από 432

MOST POPULAR

New Class of Compounds Rewires Cancer Cells to Self-Destruct

29 Αυγούστου, 2023

Hospital Mistakenly Gave Woman a Mastectomy, Then Postponed Her Reconstruction for...

12 Ιουλίου, 2021

Ivosidenib and Azacitidine Combination Shows Significant Clinical Benefit in Patients with...

26 Απριλίου, 2022

Welcome to our new committee chairs

22 Νοεμβρίου, 2022

Φόρτωση περισσοτέρων

FDA Grants Accelerated Approval to Elranatamab-bcmm for Multiple Myeloma

EMA Adopts a Positive Opinion for Dabrafenib for the Treatment of...

NALIRIFOX Improves Survival Compared with Nab-paclitaxel Plus Gemcitabine in First-Line Treatment...

2023 ASCO Annual Meeting Research Round Up: Improving Symptom Monitoring and...

A Robust, Durable Activity of Atezolizumab Observed in a Diverse Cohort...

Could Bacteria Help Find Cancer?

No Clinically Meaningful Difference in Survival Between Nivolumab Plus Ipilimumab and...

Does Eating Processed Meat Increase Your Risk for Cancer?

Dabrafenib Plus Trametinib Improves Efficacy in Children and Adolescents with Relapsed/Refractory...

Sacituzumab Govitecan Demonstrates Overall Survival Benefit Over Chemotherapy in Patients with...

MOST POPULAR

New Class of Compounds Rewires Cancer Cells to Self-Destruct

Hospital Mistakenly Gave Woman a Mastectomy, Then Postponed Her Reconstruction for...

Ivosidenib and Azacitidine Combination Shows Significant Clinical Benefit in Patients with...

Welcome to our new committee chairs

HOT NEWS

FDA grants accelerated approval to iberdomide with daratumumab and hyaluronidase-fihj and...

Wishes for a New Year!

High Frequency of Germline ATM Variants in CLL

ESMO Targeted Anticancer Therapies Congress 2023

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ